Jay Piccirillo

Medicine & Life Sciences

1. Tinnitus 100%
2. Comorbidity 85%
3. Head and Neck Neoplasms 83%
4. Sino-Nasal Outcome Test 53%
5. Survival 50%
6. Squamous Cell Carcinoma 48%
7. Sinusitis 45%
8. Health Care Outcome Assessment 36%
9. Neoplasms 35%
10. Otolaryngology 30%
11. Arnold-Chiari Malformation 30%
12. Neck 25%
13. Hereditary Hemorrhagic Telangiectasia 24%
14. Therapeutics 24%
15. Randomized Controlled Trials 23%
16. Head 23%
17. Laryngeal Neoplasms 22%
18. Quality of Life 19%
19. Confidence Intervals 18%
20. Databases 18%
21. Squamous Cell Carcinoma of Head and Neck 17%
22. Obstructive Sleep Apnea 17%
23. Neoplasm Staging 17%
24. Survival Rate 17%
25. Epidemiology 16%
26. Ecological Momentary Assessment 15%
27. Odds Ratio 15%
28. Radiotherapy 14%
29. Guidelines 14%
30. Nasal Polyps 14%
31. Drug Therapy 13%
32. Hearing Loss 13%
33. Mouth 13%
34. Recurrence 13%
35. Oropharyngeal Neoplasms 12%
36. Second Primary Neoplasms 12%
37. Nose 12%
38. Sleep Apnea Syndromes 12%
39. Cohort Studies 12%
40. Placebos 12%
41. Psychometrics 11%
42. Medicare 11%
43. Mortality 11%
44. Oropharynx 10%
45. Dizziness 10%
46. Transcranial Magnetic Stimulation 10%
47. Tongue 10%
48. Equipment and Supplies 10%
49. Multivariate Analysis 10%
50. Adjuvant Chemotherapy 10%